A trial carried out entirely in Catalonia has shown that therapy with dolutegravir plus lamivudine has an efficacy similar to that of triple therapy.1
The study, led by CIBERES, included the participation of IDIBAPS and was published in the Journal of Internal Medicine.
The transparency agreement on the use of animals in scientific experimentation in Spain is a document promoted by the Spanish Confederation of Scient1
A study by CIBERSAM with the participation of Hospital Clínic-IDIBAPS found that treatment-resistant depression has a mean incidence in Spain of 0.931
Researchers from the CLÍNIC-IDIBAPS, the Hospital Universitari Vall d’Hebron and the Parc Taulí de Sabadell have shown the damage caused by the SARS-1
The study, carried out by researchers from the IDIBAPS research group Transversal research in primary care, has been published in Annals of Family Me1
An interview with Dr Albert Lladó, neurologist at the Alzheimer's and other Cognitive Disorders Unit. Dr Lladó treats dementias, including Alzheimer'1
IDIBAPS management has approved the appointment of doctor Michela Bertero as the new IDIBAPS director of strategy. The decision was made following an1
Researchers at IDIBAPS have led a study, published in the journal Gastroenterology, in which they analyzed the clinical trials published in the past1
The study, led by researchers from the IDIBAPS group Neuronal control of metabolism, has identified the mechanism that favors the onset of obesity in1
